by Anderson Triggs, MBA | Jun 16, 2025 | Blog, Men's Health, News, Testosterone
The U.S. Food and Drug Administration (FDA) has reversed course on a crucial health issue involving drug safety, this time, regarding testosterone therapy. Based on the findings of the TRAVERSE clinical trial as well as post-market ambulatory blood pressure (ABPM)...
